26MO Efficacy and safety of poziotinib in treatment-naïve HER2 exon 20 insertion (ex20ins) mutated non-small cell lung cancer (NSCLC): ZENITH20-4

• DOI: 10.1016/j.annonc.2022.01.035
• Publication Date: 2022-03-08T11:03:37Z
• Authors: S. Sun; A. Prelaj; C. Baik; X. Le; M. Garassino; M. Wollner; E. Haura; Z. Piotrowska; M. Socinski; L. Dreiling; G. Bhat; F. Lebel; R. Cornelissen
• Keywords: Clinical endpoint